Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 20,000 shares at $4.20 ($85K) on 2008-01-09, disclosed to the SEC on 2008-01-10.
Open-market purchase of $85k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 200 | $834 | 1.0% |
| 2 | $4.18 | 200 | $836 | 1.0% |
| 3 | $4.19 | 500 | $2K | 2.5% |
| 4 | $4.20 | 1,400 | $6K | 6.9% |
| 5 | $4.21 | 600 | $3K | 3.0% |
| 6 | $4.22 | 2,300 |
| $10K |
| 11.5% |
| 7 | $4.23 | 1,900 | $8K | 9.5% |
| 8 | $4.24 | 800 | $3K | 4.0% |
| 9 | $4.25 | 12,100 | $51K | 60.7% |
| Total | $4.24 avg | 20,000 | $85K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |